Viral Hepatitis ( plus Antiviral Therapy) Efficacy of telaprevir-based triple therapy for genotype 1 hepatitis patients in Japan

被引:0
|
作者
Sasaki, Masato
Yoshida, Kenichi
Inamura, Kazuki
Obata, Masahiro
Yoshinari, Motonari
Idegami, Junko
Tanaka, Hideki
机构
关键词
hepatitis C; telaprevir; interferon; IL28b;
D O I
暂无
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
引用
收藏
页码:423 / 423
页数:1
相关论文
共 50 条
  • [1] Efficacy and factors associated with SVR in telaprevir-based triple therapy in hepatitis C patients
    Sasaki, Masato
    Tanaka, C.
    Obata, Masahiro
    Takeguchi, Masataka
    Matsushita, Hiroshi
    Yoshida, Kenichi
    [J]. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2014, 29 : 202 - 203
  • [2] Efficacy of telaprevir-based therapy in stable liver transplant patients with chronic genotype 1 hepatitis C
    Forns, Xavier
    Samuel, Didier
    Mutimer, David
    Fagiuoli, Stefano
    Navasa, Miguel
    Agarwal, Kosh
    Berenguer, Marina
    Colombo, Massimo
    Herzer, Kerstin
    Nevens, Frederik
    Daems, Bjorn
    Janssen, Katrien
    Ouwerkerk-Mahadevan, Sivi
    Kimko, Holly
    Lathouwers, Erkki
    Witek, James
    Van Solingen-Ristea, Rodica
    [J]. ANNALS OF HEPATOLOGY, 2016, 15 (04) : 512 - 523
  • [3] Efficacy of telaprevir-based therapy for difficult-to-treat patients with genotype 2 chronic hepatitis C in Japan
    Kumada, Hiromitsu
    Sato, Ken
    Takehara, Tetsuo
    Nakamuta, Makoto
    Ishigami, Masatoshi
    Chayama, Kazuaki
    Toyota, Joji
    Suzuki, Fumitaka
    Nakayasu, Yoshiyuki
    Ochi, Miyoko
    Yamada, Ichimaro
    Okanoue, Takeshi
    [J]. HEPATOLOGY RESEARCH, 2015, 45 (07) : 745 - 754
  • [4] Postmarketing surveillance of telaprevir-based triple therapy for chronic hepatitis C in Japan
    Shiraishi, Muneshige
    Umebayashi, Itsuro
    Matsuda, Hiroaki
    Sawamura, Keisuke
    Okada, Aiko
    Karino, Masako
    Nogami, Yoshihide
    [J]. HEPATOLOGY RESEARCH, 2015, 45 (13) : 1267 - 1275
  • [5] Comparative Effectiveness of Telaprevir-Based Triple Therapy in Patients With Chronic Hepatitis C
    Al-Bawardy, Badr
    Kim, W. Ray
    Poterucha, John J.
    Gross, John B.
    Charlton, Michael R.
    Larson, Joseph J.
    Colby, Colin L.
    Canterbury, Kathy
    Warner, Jennifer
    Therneau, Terry M.
    [J]. MAYO CLINIC PROCEEDINGS, 2014, 89 (05) : 595 - 601
  • [6] Telaprevir-based and simeprevir-based interferon triple therapy for patients with hepatitis C
    Sasaki, Masato
    Tanaka, Hideki
    Takeguchi, Masataka
    Mochinaga, Takaho
    Matsushita, Hiroshi
    Kurano, Soutaro
    Nakamura, Aiko
    Yoshida, Kenichi
    [J]. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2015, 30 : 382 - 382
  • [7] Successful eradication of genotype 4 HCV with telaprevir-based triple antiviral therapy
    Deneke, M. G.
    Dranoff, J. A.
    Duarte-Rojo, A.
    [J]. REVISTA DE GASTROENTEROLOGIA DE MEXICO, 2014, 79 (01): : 64 - 66
  • [8] Efficacy and safety of telaprevir-based triple therapy for patients aged 66 years and older with genotype 1b chronic hepatitis C
    Yamagiwa, Satoshi
    Ishikawa, Toru
    Tsubata, Shunsuke
    Waguri, Nobuo
    Sugitani, Soichi
    Wakabayashi, Hiroto
    Takamura, Masaaki
    Igarashi, Masato
    Nomoto, Minoru
    [J]. HEPATOLOGY, 2014, 60 : 691A - 692A
  • [9] Telaprevir-based Triple Therapy for Retreatment of Chronic Hepatitis C Patients with Genotype Four Followed in Our Clinic
    Bestepe Dursun, Zehra
    Celik, Ilhami
    [J]. VIRAL HEPATIT DERGISI-VIRAL HEPATITIS JOURNAL, 2016, 22 (02): : 58 - 61
  • [10] Pulmonary sarcoidosis in the context of a telaprevir-based triple therapy for hepatitis C
    Perez Parente, D.
    Suarez Santamaria, M.
    Suarez Ordonez, S.
    Morano Amado, L. E.
    [J]. REVISTA PORTUGUESA DE PNEUMOLOGIA, 2016, 22 (01) : 57 - 59